Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 3/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3297828 | 0.85 | TAAR1 (0.42) | TAAR1KDM4EL3MBTL1 | |
| SCHEMBL3301588 | 0.84 | MAPT (0.43) | HSD17B10KDM4EL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL3299978 | 0.80 | GRIN2D (0.31) | — | |
| SCHEMBL3299672 | 0.80 | MAPT (0.39) | KDM4EL3MBTL1MEN1ALDH1A1KMT2A | |
| SCHEMBL3294269 | 0.78 | CA2 (0.48) | KDM4EALDH1A1 | |
| SCHEMBL3299000 | 0.75 | NQO2 (0.43) | KDM4EALDH1A1 | |
| SCHEMBL12325012 | 0.74 | HSD17B1 (0.59) | TAAR1HSD17B1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL3296512 | 0.73 | L3MBTL1 (0.43) | HSD17B10KDM4EL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL11950523 | 0.72 | CA2 (0.48) | TAAR1HSD17B1KMT2A | |
| SCHEMBL321697 | 0.72 | KDM4E (0.53) | TAAR1KDM4EMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7741393-B2 | Organic silicon-based compound and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | ARSA, OR10J3, HDAC10 | TAAR1 866/4885HSD17B1 1602/4885HSD17B10 955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.